Arbutus Biopharma Corporation Insider Trading

ABUS

⊜ Compare

Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in Aug 2015.

Net open-market

0 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

0 / 0

executives and directors

Last open-market buy

Aug 2015

Aug 24, 2015

Get an email when ABUS's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Feb 4, 2025	David C Hastings Chief Financial Officer	Sold10b5-1 plan	22,183	$3.28	73K	12%	Form 4
Feb 4, 2025	Karen Sims Chief Medical Officer	Sold10b5-1 plan	19,348	$3.28	63K	15%	Form 4
Feb 4, 2025	Michael J. McElhaugh Interim President & CEO	Sold10b5-1 plan	23,790	$3.28	78K	1.6%	Form 4
Feb 4, 2025	J. Christopher Naftzger General Counsel and CCO	Sold10b5-1 plan	11,333	$3.28	37K	12%	Form 4

Feb 4, 202510b5-1 plan
David C Hastings
Chief Financial Officer · sold 22,183 at $3.28
73K
12% of stake
Feb 4, 202510b5-1 plan
Karen Sims
Chief Medical Officer · sold 19,348 at $3.28
63K
15% of stake
Feb 4, 202510b5-1 plan
Michael J. McElhaugh
Interim President & CEO · sold 23,790 at $3.28
78K
1.6% of stake
Feb 4, 202510b5-1 plan
J. Christopher Naftzger
General Counsel and CCO · sold 11,333 at $3.28
37K
12% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ABUS, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with ABUS

CompareIntrinsic value

AMRNAmarin Corp PLC\Uk

$12.25+1.66%46

CYRXCryoport Inc.

$16.70+1.52%13

URGNUrogen Pharma Ltd.

$28.71-16.54%30

SLNOSoleno Therapeutics Inc

No recent price25

LFVNLifeVantage Corporation

$5.97+3.65%73

DAWNDay One Biopharmaceuticals, Inc.

No recent price10

MGNXMacrogenics Inc.

$2.31-0.86%36

MRVIMaravai Lifesciences Holdings Inc.

$7.72+3.62%10

Held by ETFs

ABUS is in 27 US ETFs. The largest of them, with ABUS's weight in each:

Spot a number that looks wrong? Check it in ABUS's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ABUS

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.